Thanks for posting the link, each time I watch this Liau video I see something I missed before. Liau is a clear leader in the field and obviously a believer in the vaccine. With the current study should at least do great things for certain subgroups, I hope the new SAP includes this subgroup analysis. Liau and her team are taking it to the next level with combination therapy, just hope dcvax alone is good enough to get a chance for approval, then add in combination therapy to make it better Good luck to all
Yes, so now its 2020 we have 5 years of data and majority of the patients were given dcvax-L and overall survival is longer. LP wanted a home run on the long tail and she delivered, so here comes Merck Dr Duffy to validate and help with the SAP so after TLD in mid July kaboom! Merck’s buyout announced.